Zenas BioPharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Zenas BioPharma, Inc. (ZBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.30 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.93M shares, a 22.42% decline year-over-year.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 371.40K shares, a 243.89% increase year-over-year.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 110.00K shares.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 2.49M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2026-06-30 | 1.93M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 2.30M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 371.40K shares 10-Q · filed 2026-05-13 | ||
| 2025-09-30 | 110.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 2.60M shares derived: sum of 2 quarters · filed 2025-11-12 | 2.70M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 2.49M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 2.59M shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 108.00K shares 10-Q · filed 2025-05-15 |